FDA Inspection 987875 — UF Reproductive Medicine at Springhill

UF Reproductive Medicine at Springhill — FEI 3003926999

The FDA completed an inspection of UF Reproductive Medicine at Springhill on September 27, 2016 in Gainesville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 27, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Gainesville, FL (United States)